Miconazole

Miconazole

SCHEMBL9954418

Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+](O)O.[Au+]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Miconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.90
LMNA P02545 5/20 0.90
MEN1 O00255 4/20 0.90
KMT2A Q03164 4/20 0.90
TDP1 Q9NUW8 4/20 0.90
USP2 O75604 3/20 0.90
HIF1A Q16665 3/20 0.90
TP53 P04637 2/20 0.90
GAA P10253 2/20 0.90
MAPT P10636 2/20 0.90
MAPK1 P28482 2/20 0.90
HTT P42858 2/20 0.90
RECQL P46063 2/20 0.90
NPSR1 Q6W5P4 2/20 0.90
ALPL P05186 1/20 0.90
IDO1 P14902 11/20 0.86
CYP2C9 P11712 6/20 0.86
CYP1A2 P05177 4/20 0.86
CYP2D6 P10635 4/20 0.86
CYP2C19 P33261 4/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Miconazole SCHEMBL21359032 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
(R)-Miconazole SCHEMBL15800 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL8012623 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL8178405 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL15799 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL29383982 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL8014818 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL8160353 0.95 CYP3A4 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL9662051 0.93 IDO1 (1.00) CYP3A4LMNAMEN1KMT2ATDP1
Miconazole SCHEMBL2866 0.93 IDO1 (1.00) CYP3A4LMNAMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140030201-A1 A SKIN LIGHTENING COMPOSITION CONOPCO, INC., D/B/A UNILEVER 2014-01-30 US disclosed
WO-2012084309-A2 A SKIN LIGHTENING COMPOSITION UNILEVER PLC (GB) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140030201-A1 A SKIN LIGHTENING COMPOSITION CRY1, CRY2, TYR CYP3A4 988/4885LMNA 2233/4885MEN1 379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.